Site‐specific chemotherapy based on gene expression profiling versus empirical chemotherapy for people with cancer of unknown primary site
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Site‐specific Chemotherapy Based On Gene Expression Profiling Versus Empirical Chemotherapy for People With Cancer of Unknown Primary Site." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/431989/all/Treatment_for_amphetamine_psychosis:_Cochrane_systematic_review. Accessed 29 March 2024.
Site‐specific chemotherapy based on gene expression profiling versus empirical chemotherapy for people with cancer of unknown primary site. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/431989/all/Treatment_for_amphetamine_psychosis:_Cochrane_systematic_review. Accessed March 29, 2024.
Site‐specific chemotherapy based on gene expression profiling versus empirical chemotherapy for people with cancer of unknown primary site. In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/431989/all/Treatment_for_amphetamine_psychosis:_Cochrane_systematic_review
Site‐specific Chemotherapy Based On Gene Expression Profiling Versus Empirical Chemotherapy for People With Cancer of Unknown Primary Site [Internet]. In: Cochrane Abstracts. [cited 2024 March 29]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/431989/all/Treatment_for_amphetamine_psychosis:_Cochrane_systematic_review.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Site‐specific chemotherapy based on gene expression profiling versus empirical chemotherapy for people with cancer of unknown primary site
ID - 431989
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/431989/all/Treatment_for_amphetamine_psychosis:_Cochrane_systematic_review
DB - Evidence Central
DP - Unbound Medicine
ER -